Bavarian Nordic: State gains from vaccine support capped by contract
Bavarian Nordic's potential corona vaccine will not be a gold mine investment for the Danish state, the biotech company's CFO says, as their agreement includes a cap on royalties.
BY RITZAU FINANS, TRANSLATED BY CATHERINE BRETT
After obtaining EUR 108m (DKK 800m) in financial aid from the Danish state, Bavarian Nordic has the opportunity to create a lucrative business before the state wants any of that money back.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
